Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview

Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview

Osteoporosis resulting from an imbalance of bone turnover between resorption and formation is a critical health issue worldwide. Estrogen deficiency following a nature aging process is the leading cause of hormone-related osteoporosis for postmenopausal women, while glucocorticoid-induced osteoporos...

Full description

Bibliographic Details
Main Authors:	Li-Ting Wang, Li-Ru Chen, Kuo-Hu Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	osteoporosis hormone estrogen glucocorticoid nuclear factor-κβ ligand (RANKL) osteoprotegerin (OPG)
Online Access:	https://www.mdpi.com/1422-0067/24/6/5814

Similar Items

Functionalized calcium phosphate nanoparticles to direct osteoprotegerin to bone lesion sites in a medaka (Oryzias latipes) osteoporosis model
by: Nurgul Imangali, et al.
Published: (2023-02-01)

The Pathophysiology of Osteoporosis after Spinal Cord Injury
by: Ramsha Shams, et al.
Published: (2021-03-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
by: Salvador Atilano-Miguel, et al.
Published: (2022-01-01)

Lycopene ameliorates diabetic osteoporosis via anti-inflammatory, anti-oxidation, and increasing Osteoprotegerin/RANKL expression ratio
by: Shan Shan Qi, et al.
Published: (2021-08-01)

Diosmin mitigates dexamethasone-induced osteoporosis in vivo: Role of Runx2, RANKL/OPG, and oxidative stress
by: El-Shaimaa A. Arafa, et al.
Published: (2023-05-01)

Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
by: Zhao Y, et al.
Published: (2020-01-01)

OPG/RANKL/RANK cytokine system in renal osteodystrophy
by: Ivica Avberšek-Lužnik, et al.
Published: (2007-11-01)

S-Equol enhances osteoblastic bone formation and prevents bone loss through OPG/RANKL via the PI3K/Akt pathway in streptozotocin-induced diabetic rats
by: Zhe Xu, et al.
Published: (2022-10-01)

<it>Eurycoma longifolia</it> upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model
by: Shuid Ahmad, et al.
Published: (2012-09-01)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
by: Guanghao Chi, et al.
Published: (2023-11-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

A single-center study of bone mineral density in adult patients with severe hemophilia A in correlation with markers of bone metabolism
by: Hristina A. Ivanova, et al.
Published: (2023-02-01)

Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
by: Xiao-Feng He, et al.
Published: (2017-11-01)

Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
by: Filip Przerwa, et al.
Published: (2023-12-01)

ATHEROSCLEROSIS, VASCULAR CALCIFICATION AND BONE LOSS (OSTEOPOROSIS): COMMON PATHOPHYSIOLOGICAL MRCHANISMS DEVELOPMENT OF THE DESEASES AND RESEARCH NOVEL DRAGS FOR DUAL THERAPIE
by: A. Dolzhenko, et al.
Published: (2016-12-01)

Evaluation of toxicity and anti-osteoporosis effect in rats treated with the flavonoids of Psoraleae Fructus
by: Bojia Liu, et al.
Published: (2020-12-01)

Protection against Osteoporosis by Fermented Mulberry Vinegar Supplementation via Inhibiting Osteoclastic Activity in Ovariectomized Rats and Osteoclastic Cells
by: Eun Jung Yim, et al.
Published: (2022-05-01)

Relationship between Lipid Profile and Bone Turnover in Pre and Postmenopausal Women
by: H Saghafi, et al.
Published: (2008-11-01)

Relationship between Lipid Profile and Bone Turnover in Pre and Postmenopausal Women
by: H Saghafi, et al.
Published: (2008-12-01)

Relationship between Lipid Profile and Bone Turnover in Pre and Postmenopausal Women
by: H Saghafi, et al.
Published: (2008-11-01)

Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study
by: Sara Bindoli, et al.
Published: (2019-09-01)

Changes in Serum Bone Metabolism Markers after Living Donor Liver Transplantation (LDLT) and Their Association with Fracture Occurrences
by: Shu-Jui Kuo, et al.
Published: (2023-06-01)

An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis
by: Weidong Weng, et al.
Published: (2022-04-01)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
by: Dured Dardari, et al.
Published: (2022-04-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
by: Riham Eid, et al.
Published: (2023-06-01)

Vitamin D(3) and methylenebisphosphonic acid in the correction of mineral metabolism disorders and bone remodeling associated with glucocorticoid-induced osteoporosis
by: O. O. Lisakovska, et al.
Published: (2023-04-01)

Generalized osteoporosis of mixed origin with severe compression fractures and pain syndrome
Published: (2013-12-01)

Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover
by: Chu-Han Cheng, et al.
Published: (2022-01-01)

Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis
by: Xu Han, et al.
Published: (2022-11-01)

The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis
by: Ansari Moghadam S, et al.
Published: (2019-08-01)

Osteoimmunological Insight in to Vertebral Fractures in Osteoporosis
by: H Saghafi, et al.
Published: (2008-11-01)

Osteoimmunological Insight in to Vertebral Fractures in Osteoporosis
by: H Saghafi, et al.
Published: (2008-12-01)

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study
by: Osama E. Amer, et al.
Published: (2022-07-01)

Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair
by: Zineb Bouredji, et al.
Published: (2021-06-01)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
by: Piet Geusens
Published: (2009-06-01)

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
by: Bai Peng, et al.
Published: (2011-12-01)

Bone Remodeling Markers in Children with Acute Lymphoblastic Leukemia after Intensive Chemotherapy: The Screenshot of a Biochemical Signature
by: Paola Muggeo, et al.
Published: (2023-04-01)

Vitamin D3 Modulates Impaired Crosstalk Between RANK and Glucocorticoid Receptor Signaling in Bone Marrow Cells After Chronic Prednisolone Administration
by: Ihor Shymanskyi, et al.
Published: (2018-06-01)

Corrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats
by: Hao Wu, et al.
Published: (2020-11-01)

Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
by: Asieh Mansour, et al.
Published: (2018-07-01)